|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - $153.10 /
+4.135 (+2.78%) - 17:25 Today
- Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B
- 17:18 Today
- Meta says 2023 will be 'a year of efficiency'
- 16:14 Today
- Meta Platforms announces $40B increase in share repurchase authorization
- 16:10 Today
- Meta Platforms reports FoA and RL segment restructuring charges
- $282.22 /
+12.72 (+4.72%) - 16:06 Today
- Align Technology board authorizes $1B buyback to succeed current program
- 10/31/22
- Align Technology CEO Joe Hogan to purchase additional $2M of common stock
- 10/31/22
- Align Technology announces $200M accelerated share repurchase agreement
- 10/26/22
- Align Technology falls 20% to $177.50 after Q3 results misses estimates
- 11/03/22
- e.l.f. Beauty rises 10.2%
- 12/05/22
- Ezcorp increases investment in Florida and Caribbean
- 11/17/22
- EZCORP trading resumes
- 11/17/22
- EZCORP trading halted, volatility trading pause
- 08/22/22
- Ezcorp launches Buy More, Earn More promotion
- 01/18/23
- 8x8 announces approximately 7% reduction in workforce
- 12/13/22
- Matterport appoints Matthew Zinn as chief legal officer
- 12/08/22
- Spearline acquires Callstats from 8x8, terms not disclosed
- 11/30/22
- 8x8 terminates CEO Dave Sipes, Samuel Wilson named interim CEO
- 12/30/22
- Intevac signs joint development agreement with glass, glass ceramic provider
- 10/26/22
- Intevac gets $12M order for hard disk drive technology upgrades
- 12/06/22
- Hologic's new data identifies patients benefiting from endocrine therapy
- 11/25/22
- Hologic to showcase portfolio of breast, skeletal health solutions at RSNA 2022
- 11/02/22
- Hologic awarded $19M BARDA contract
- 10/23/22
- Fly Intel: Top five weekend stock stories
- 01/17/23
- Core Laboratories proposes redomestication of parent company to U.S.
- 10/26/22
- Core Laboratories CEO sees progress in onshore and offshore client activity
- 09/29/22
- McKesson extends pharmaceutical distribution agreement with CVS Health
- 09/19/22
- McKesson signs agreement to acquire Rx Savings Solutions
- 09/19/22
- McKesson to acquire Rx Savings Solutions for $600M upfront
- 09/13/22
- McKesson names LeAnn Smith chief human resources officer
- 16:36 Today
- Tenax receives NOA from USPTO for patent for levosimendan in PH-HFpEF
- 01/04/23
- Tenax Therapeutics announces 1-for-20 reverse stock split
- 10/10/22
- Tenax Therapeutics announces presentation of data from study of levosimendan
- 09/15/22
- Tenax Therapeutics trading resumes
- 10/05/22
- ChampionX's US Synthetic weighs challenge to patent ruling
- 09/29/22
- ChampionX publishes first sustainability report
- 10/19/22
- MaxLinear, SoftAtHome team on prpl LCM solution for home gateways
- 09/01/22
- Digi International selects MaxLinear PCIe bridges, serial transceivers
- 08/31/22
- Silicon Motion shareholders approve acquisition by MaxLinear
- 11/17/22
- PTC to acquire ServiceMax for $1.46B in cash
- 11/14/22
- Lone Pine adds Autodesk stake, reduces Meta Platforms, Microsoft stakes
- $101.99 /
+1.755 (+1.75%) - 16:11 Today
- C.H. Robinson sees 2023 capital expenditures $90M-$100M
- 01/03/23
- C.H. Robinson CEO Bob Biesterfeld steps down, Scott Anderson named interim CEO
- 11/17/22
- C.H. Robinson raises quarterly dividend to 61c per share from 55c
- 11/02/22
- C.H. Robinson sees $175M of gross cost savings in Q4
- 12/20/22
- Corteva Agriscience, Nevonex announce collaboration agreement
- 11/30/22
- Corteva to acquire Stoller Group for $1.2B
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 10/03/22
- Syngenta, Corteva sued by FTC for pay-to-black scheme
- 11/28/22
- Qorvo partners with MediaTek to secure design wins
- 11/02/22
- Qorvo, SK Siltron CSS enter SiC supply agreement
- 11/02/22
- Qorvo announces $2B share repurchase program
- 08/30/22
- Qorvo appoints Grant Brown as CFO
- 10/27/22
- Century Communities falls -12.0%
- 10/26/22
- Century Communities CFO provides FY22 outlook
- 01/30/23
- Vera Therapeutics reports Phase 2 results of atacicept in IgA nephropathy
- 01/25/23
- Vera Therapeutics to host KOL webinar on atacicept
- 01/03/23
- Vera Therapeutics shares fall 67% despite ORIGIN trial meeting primary endpoint
- 01/03/23
- Vera Therapeutics announces ORIGIN clinical trial met primary endpoint
- 01/04/23
- Roivant Sciences up 9% in pre-market at $7.78 after RVT-3101 phase 2b study data
- 01/04/23
- Roivant Sciences announces 'positive' results from Phase 2b study of RVT-3101
- 12/01/22
- Roivant Sciences, Pfizer form new Vant company focused on developing RVT-3101
- 11/10/22
- Roivant's Affivant to present data on AFVT-2101 at SITC
- $153.10 /
+4.135 (+2.78%) - 01/31/23 LightShed Partners
- Meta Platforms initiated with a Buy at LightShed Partners
- 01/30/23 DA Davidson
- DA Davidson neutral on Pinterest ahead of earnings
- 01/27/23 BofA
- BuzzFeed still a 'show me story,' Meta deal not new, says BofA
- 01/26/23 Piper Sandler
- Meta Platforms price target raised to $136 from $116 at Piper Sandler
- $282.22 /
+12.72 (+4.72%) - 01/11/23 Piper Sandler
- Align Technology price target raised to $255 from $230 at Piper Sandler
- 10/27/22 Stifel
- Align Technology price target lowered to $265 from $325 at Stifel
- 10/27/22 Baird
- Align Technology price target lowered to $260 from $310 at Baird
- 10/27/22 Piper Sandler
- Align Technology price target lowered to $230 from $300 at Piper Sandler
- 01/24/23 Stifel
- e.l.f. Beauty price target raised to $50 from $43 at Stifel
- 01/13/23 JPMorgan
- e.l.f. Beauty price target raised to $65 from $62 at JPMorgan
- 01/09/23 Jefferies
- e.l.f. Beauty downgraded to Hold from Buy at Jefferies
- 01/03/23 Piper Sandler
- e.l.f. Beauty price target raised to $64 from $55 at Piper Sandler
- 01/04/23 Canaccord
- Canaccord starts Ezcorp with a Buy, says discount 'undeserved'
- 01/04/23 Canaccord
- Ezcorp initiated with a Buy at Canaccord
- 04/05/22 Jefferies
- Ezcorp upgraded to Buy from Hold at Jefferies
- 12/15/22 Wedbush
- Wedbush starts 8x8 with a Neutral as momentum slows
- 12/14/22 Wedbush
- 8x8 initiated with a Neutral at Wedbush
- 12/02/22 Craig-Hallum
- Craig-Hallum sees 'tremendous logic' in RingCentral, 8x8 combination
- 10/28/22 Barclays
- 8x8 price target lowered to $4 from $5 at Barclays
- 01/03/23 Benchmark
- Intevac upgraded to Buy at Benchmark following TRIO agreement
- 01/03/23 Benchmark
- Intevac upgraded to Buy from Hold at Benchmark
- 02/10/22 Benchmark
- Intevac downgraded to Hold from Buy at Benchmark
- 01/24/23 Mizuho
- Hologic price target raised to $90 from $77 at Mizuho
- 01/10/23 Wells Fargo
- Hologic price target raised to $80 from $75 at Wells Fargo
- 12/06/22 RBC Capital
- Hologic initiated with a Sector Perform at RBC Capital
- 11/16/22 Evercore ISI
- Evercore ISI removes seven Healthcare Services and Tech stocks from 'TAP' list
- 01/09/23 BofA
- Core Laboratories upgraded to Neutral from Underperform at BofA
- 10/07/22 Piper Sandler
- Core Laboratories assumed with a Neutral at Piper Sandler
- 10/06/22 Citi
- Citi upgrades Core Laboratories to Neutral following pullback
- 10/06/22 Citi
- Core Laboratories upgraded to Neutral from Sell at Citi
- 01/31/23 UBS
- McKesson price target lowered to $440 from $450 at UBS
- 01/11/23 Baird
- McKesson price target raised to $445 from $440 at Baird
- 11/14/22 Mizuho
- McKesson price target raised to $376 from $345 at Mizuho
- 11/02/22 Cowen
- McKesson price target raised to $416 from $384 at Cowen
- 11/01/22 Citi
- ChampionX price target raised to $34 from $30 at Citi
- 10/07/22 Piper Sandler
- ChampionX assumed with an Overweight at Piper Sandler
- 10/06/22 Barclays
- ChampionX downgraded on less potential upside potential at Barclays
- 10/06/22 Barclays
- ChampionX downgraded to Equal Weight from Overweight at Barclays
- 11/02/22 Needham
- Silicon Motion upgraded to Buy at Needham after 'better than feared' report
- 10/26/22 Northland
- MaxLinear price target lowered to $35 from $45 at Northland
- 10/26/22 Craig-Hallum
- MaxLinear price target lowered to $55 from $65 at Craig-Hallum
- 10/26/22 Susquehanna
- MaxLinear price target lowered to $42 from $45 at Susquehanna
- 01/30/23 RBC Capital
- PTC price target raised to $155 from $140 at RBC Capital
- 01/26/23 Baird
- PTC price target raised to $165 from $150 at Baird
- 01/23/23 KeyBanc
- PTC upgraded to Overweight from Sector Weight at KeyBanc
- 01/11/23 Barclays
- PTC price target lowered to $144 from $148 at Barclays
- $101.99 /
+1.755 (+1.75%) - 01/17/23 BofA
- Schneider, Werner upgraded to Buy, XPO Logistics downgraded at BofA
- 01/17/23 BofA
- C.H. Robinson downgraded to Underperform from Neutral at BofA
- 01/11/23 JPMorgan
- C.H. Robinson downgraded to Neutral from Overweight at JPMorgan
- 01/11/23 KeyBanc
- C.H. Robinson price target lowered to $110 from $120 at KeyBanc
- 01/20/23 Citi
- Corteva price target lowered to $72 from $75 at Citi
- 01/18/23 Wells Fargo
- Corteva initiated with an Overweight at Wells Fargo
- 01/18/23 Wells Fargo
- Corteva initiated with an Overweight at Wells Fargo
- 01/11/23
- BofA shakes up ratings to get 'more offensive' in U.S. Chemicals
- 01/23/23 Barclays
- Qorvo price target raised to $110 from $85 at Barclays
- 01/17/23 Citi
- Citi opens 'positive catalyst watch' on Qorvo
- 01/11/23 KeyBanc
- KeyBanc says iPhone survey shows supply partial recovery, some shortages remain
- 01/09/23 Wells Fargo
- Qorvo price target raised to $90 from $80 at Wells Fargo
- 01/20/23 B. Riley
- Century Communities price target raised to $49 from $44 at B. Riley
- 12/30/22 Wedbush
- Wedbush favors four homebuilding stocks heading into 2023
- 11/29/22 BTIG
- Century Communities initiated with a Neutral at BTIG
- 11/22/22 JPMorgan
- Century Communities downgraded to Underweight from Overweight at JPMorgan
- 01/04/23 Jefferies
- Vera Therapeutics downgraded to Hold from Buy at Jefferies
- 01/04/23 Wedbush
- Wedbush downgrades Vera Therapeutics to Neutral, lowers price target to $8
- 01/04/23 Wedbush
- Vera Therapeutics downgraded to Neutral from Outperform at Wedbush
- 01/04/23 H.C. Wainwright
- Vera Therapeutics price target lowered to $15 from $36 at H.C. Wainwright
- 01/05/23 Citi
- Roivant Sciences price target raised to $14 from $11 at Citi
- 01/04/23 Piper Sandler
- Prometheus, Roivant TL1A data look 'highly competitive,' says Piper
- 12/28/22 Cantor Fitzgerald
- Cantor calls Merck top large cap pharma pick, names 8 SMID cap top picks
- 12/27/22 Cantor Fitzgerald
- Roivant's upcoming data readouts could move stock higher, says Cantor Fitzgerald
- $153.10 /
+4.135 (+2.78%) - 16:06 Today
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 16:06 Today
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 13:48 Today
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- $282.22 /
+12.72 (+4.72%) - 16:05 Today
- Align Technology reports Q4 EPS $1.73, consensus $1.56
- 13:48 Today
- Notable companies reporting after market close
- 10/26/22
- Align Technology reports Q3 adjusted EPS $1.36, consensus $2.18
- 16:10 Today
- e.l.f. Beauty raises FY23 adjusted EPS view to $1.37-$1.40 from $1.07-$1.10
- 16:09 Today
- e.l.f. Beauty reports Q3 adjusted EPS 48c, consensus 23c
- 11/02/22
- e.l.f. Beauty raises FY23 EPS view to $1.07-$1.10 from 84c-87c
- 11/02/22
- e.l.f. Beauty reports Q2 EPS 36c, consensus 16c
- 16:21 Today
- Ezcorp reports Q1 adjusted EPS 28c, consensus 22c
- 11/16/22
- Ezcorp reports Q4 adjusted EPS 15c, one estimate 12c
- 08/03/22
- Ezcorp reports Q3 adjusted EPS 16c, consensus 5c
- 16:07 Today
- 8x8 raises FY23 revenue view to $743.4M-$746.4M from $720M-$730M
- 16:07 Today
- 8x8 sees Q4 revenue $184M-$187M, consensus $187.67M
- 16:06 Today
- 8x8 reports Q3 adjusted EPS 7c, consensus 3c
- 13:48 Today
- Notable companies reporting after market close
- 17:07 Today
- Intevac sees Q1 EPS (20c)-(16c), consensus (21c)
- 16:13 Today
- Intevac reports Q4 EPS (13c) vs. (25c) y/y
- 11/02/22
- Intevac sees Q4 EPS (21c)-(17c), consensus (12c)
- 08/03/22
- Intevac sees Q3 EPS (17c) to (15c), one estimate (13c)
- 16:03 Today
- Hologic raises FY23 EPS view to $3.55-$3.85 from $3.30-$3.60
- 16:02 Today
- Hologic sees Q2 adjusted EPS 80c-90c, consensus 82c
- 16:02 Today
- Hologic reports Q1 adjusted EPS $1.07, consensus 91c
- 01/08/23
- Hologic reports preliminary Q1 revenue $1.074B, consensus $966.37M
- 17:16 Today
- Core Laboratories reports Q4 EPS 20c, consensus 20c
- 10/26/22
- Core Laboratories reports Q3 EPS 18c, consensus 15c
- 16:14 Today
- McKesson raises FY23 EPS view to $25.75-$26.15 from $24.45-$24.95
- 16:13 Today
- McKesson reports Q3 adjusted EPS $6.90, consensus $6.35
- 13:48 Today
- Notable companies reporting after market close
- 11/01/22
- McKesson boosts FY23 adjusted EPS view to $24.45-$24.95 from $23.95-$24.65
- 16:36 Today
- ChampionX sees Q1 revenue $952M-$982M, consensus $994.58M
- 16:33 Today
- ChampionX reports Q4 EPS 33c, consensus 40c
- 10/25/22
- ChampionX sees Q4 revenue $985M-$1.015B, consensus $953.01M
- 10/25/22
- ChampionX reports Q3 adjusted EPS 33c, consensus 32c
- 16:07 Today
- MaxLinear sees Q1 revenue $240M-$260M, consesus $279.7M
- 16:06 Today
- MaxLinear reports Q4 adjusted EPS $1.07, consensus $1.06
- 10/25/22
- MaxLinear sees Q4 revenue $285M-$295M, consensus $285.36M
- 10/25/22
- MaxLinear reports Q3 EPS $1.05, consensus $1.04
- 16:03 Today
- PTC raises FY23 revenue view to $2.070B-$2.150B from $2.050B-$2.130B
- 16:02 Today
- PTC reports Q1 adjusted EPS 99c, consensus $1.03
- 11/02/22
- PTC sees FY23 revenue $1.91B-$1.99B, consensus $1.92B
- 11/02/22
- PTC reports Q4 adjusted EPS $1.27, consensus $1.15
- $101.99 /
+1.755 (+1.75%) - 16:09 Today
- C.H. Robinson reports Q4 adjusted EPS $1.03, consensus $1.38
- 13:48 Today
- Notable companies reporting after market close
- 11/02/22
- C.H. Robinson reports Q3 EPS $1.78, consensus $2.17
- 17:02 Today
- Corteva sees FY23 operating EPS $2.70-$2.90, consensus $3.13
- 17:01 Today
- Corteva reports Q4 adjusted EPS 16c, consensus 5c
- 11/03/22
- Corteva backs FY22 adjusted EPS view $2.45-$2.60, consensus $2.57
- 11/03/22
- Corteva reports Q3 adjusted EPS (12c), consensus (23c)
- 16:04 Today
- Qorvo sees Q4 EPS 10c-15c, consensus 64c
- 16:02 Today
- Qorvo reports Q3 EPS 75c, consensus 63c
- 13:48 Today
- Notable companies reporting after market close
- 11/02/22
- Qorvo sees Q3 EPS 50c-75c, consensus $1.69
- 16:07 Today
- Century Communities reports Q4 adjusted EPS $2.71, consensus $2.43
- 10/26/22
- Century Communities reports Q3 EPS $4.44, consensus $4.20
- 11/09/22
- Vera Therapeutics reports Q3 EPS (91c), consensus (72c)
- 08/10/22
- Vera Therapeutics reports Q2 EPS (55c) vs (33c) last year
- 11/14/22
- Roivant Sciences reports Q2 EPS (42c), consensus (41c)
- 08/15/22
- Roivant Sciences reports Q1 EPS (48c) vs (13c) last year
|
|
Hot Stocks
| ShowHide Related Items >><< - 01/25/23
- HSBC Bank Canada raises prime lending rate to 6.7% from 6.45%
- 01/03/23
- Kentucky lists BlackRock, Citi, JPMorgan as energy boycotters
- 12/14/22
- HSBC Bank USA raises prime lending rate to 7.5% from 7%
- 12/14/22
- HSBC updates climate policy to stop funding new oil, gas
- 01/30/23 Barclays
- Barclays upgrades European banks view to Positive from Neutral
- 01/16/23 Deutsche Bank
- Standard Chartered downgraded to Hold from Buy at Deutsche Bank
- 01/16/23 Deutsche Bank
- HSBC upgraded to Buy from Hold at Deutsche Bank
- 01/05/23 Jefferies
- HSBC upgraded to Buy from Hold at Jefferies
- 10/25/22
- HSBC reports Q3 EPS 10c vs. 17c last year
- 12/21/22
- HSBC beats $141M lawsuit in U.K. over Allen Stanford, Reuters says
- 11/30/22
- HSBC to close 114 branches in the U.K. starting in April, Press Association says
- 11/04/22
- Ping An calls on HSBC to spin off Asian business, cut jobs, FT reports
- 10/04/22
- HSBC weighs sale of Canadian business, Reuters reports
- 11/29/22
- What You Missed On Wall Street On Tuesday
- 11/29/22
- What You Missed On Wall Street This Morning
- 11/04/22
- What You Missed On Wall Street On Friday
- 11/04/22
- What You Missed On Wall Street This Morning
- 01/10/23
- HSBC put volume heavy and directionally bearish
- 11/02/22
- HSBC put volume heavy and directionally bearish
- 10/31/22
- HSBC put volume heavy and directionally bearish
- 10/26/22
- HSBC put volume heavy and directionally bearish
|
|
Hot Stocks
| ShowHide Related Items >><< - 12/14/22
- Deutsche Bank raises prime lending rate to 7.5% from 7%, effective December 15
- 11/02/22
- Deutsche Bank raises prime lending rate to 7% from 6.25%
- 09/27/22
- SEC charges 16 Wall Street firms with recordkeeping failures
- 09/21/22
- Deutsche Bank increases prime lending rate to 6.25%
- 01/13/23 Barclays
- Deutsche Bank price target raised to EUR 12.50 from EUR 11.50 at Barclays
- 12/06/22 JPMorgan
- Deutsche Bank price target raised to EUR 15 from EUR 13 at JPMorgan
- 11/25/22 RBC Capital
- Deutsche Bank upgraded to Outperform from Sector Perform at RBC Capital
- 11/11/22 Barclays
- Deutsche Bank price target raised to EUR 11.50 from EUR 11 at Barclays
- 10/26/22
- Deutsche Bank reaffirms 2022 revenue guidance of EUR26B-EUR27B
- 10/26/22
- Deutsche Bank reports Q3 profit before tax EUR 1.6B, post-tax profit EUR 1.2B
- 01/20/23
- Deutsche Bank to cut investment banking bonus pool by 40%, FT reports
- 01/17/23
- Lottomatica picks banks for potential IPO, Reuters reports
- 11/25/22
- Deutsche Bank, BNP to face higher capital requirements from ECB, Bloomberg says
- 11/25/22
- Deutsche Bank looks to expand deals business in Asia, Bloomberg says
- 01/20/23
- What You Missed On Wall Street On Friday
- 01/20/23
- What You Missed On Wall Street This Morning
- 11/25/22
- What You Missed On Wall Street On Friday
- 10/18/22
- What You Missed On Wall Street This Morning
- 01/09/23
- Deutsche Bank call volume above normal and directionally bullish
- 01/03/23
- Deutsche Bank call volume above normal and directionally bullish
- 12/22/22
- Deutsche Bank put volume heavy and directionally bearish
- 12/22/22
- Unusually active option classes on open December 22nd
|
|
Recommendations
| ShowHide Related Items >><< - 01/31/23
- Spotify rises 9.8%
- 01/31/23
- Spotify reports Q4 MAUs up 20% y/y to 489M
- 01/26/23
- Spotify tweets 'everything's looking much better now'
- 01/26/23
- Spotify says 'something's not quite right,' company investigating
- 08:01 Today Rosenblatt
- Spotify price target raised to $110 from $87 at Rosenblatt
- 07:09 Today JPMorgan
- Spotify price target raised to $135 from $120 at JPMorgan
- 07:01 Today Barclays
- Spotify price target raised to $145 from $131 at Barclays
- 06:32 Today KeyBanc
- Spotify price target raised to $140 from $125 at KeyBanc
- 01/31/23
- Spotify sees Q1 revenue EUR 3.1B, gross margin 24.9%
- 01/31/23
- Spotify reports Q4 EPS (EUR 1.40) vs. (EUR 0.20) last year
- 10/25/22
- Spotify reports Q3 Operating loss EUR (228M) vs. profit EUR 75M prior
- 12/13/22
- Spotify steps back from live audio programming, Bloomberg says
- 10/26/22
- Spotify to raise prices in U.S. in 2023, WSJ reports
- 10/20/22
- Spotify, FanDuel agree to deal expanding The Ringer partnership, Axios reports
- 10/12/22
- TikTok parent plans expansion in music streaming, WSJ reports
- 01/31/23
- What You Missed On Wall Street On Tuesday
- 01/31/23
- What You Missed On Wall Street This Morning
- 01/31/23
- Fly Intel: Pre-market Movers
- 01/23/23
- What You Missed On Wall Street On Monday
- 01/31/23
- Unusually active option classes on open January 31st
- 01/23/23
- Unusually active option classes on open January 23rd
- 01/19/23
- Spotify call volume above normal and directionally bullish
- 12/14/22
- Spotify put volume heavy and directionally bearish
|
|
Hot Stocks
| ShowHide Related Items >><< - $587.37 /
+17.23 (+3.02%) - 01/24/23
- Thermo Fisher, AstraZeneca team on CDx test for Tagrisso
- 01/12/23
- Thermo Fisher joins Momentum Labs as a founding sponsor of biotech hub
- 01/03/23
- Thermo Fisher completes acquisition of The Binding Site Group, sees accretion
- 01/03/23
- Aslan, Thermo Fisher announce partnership for manufacturing eblasakimab
- $587.37 /
+17.23 (+3.02%) - 01/24/23 Barclays
- Thermo Fisher price target raised to $630 from $570 at Barclays
- 01/03/23 Wells Fargo
- Thermo Fisher price target lowered to $505 from $525 at Wells Fargo
- 12/13/22 Deutsche Bank
- Thermo Fisher initiated with a Buy at Deutsche Bank
- 12/06/22 RBC Capital
- Thermo Fisher initiated with an Outperform at RBC Capital
- $587.37 /
+17.23 (+3.02%) - 09:04 Today
- Thermo Fisher sees Q1 EPS over 20% of full-year total, consensus $5.41
- 06:01 Today
- Thermo Fisher sees FY23 adjusted EPS $23.70, consensus $23.21
- 06:00 Today
- Thermo Fisher reports Q4 adjusted EPS $5.40, consensus $5.19
- 01/31/23
- Notable companies reporting before tomorrow's open
- $587.37 /
+17.23 (+3.02%) - 10/30/22
- Thermo Fisher said to near $2.3B deal for Binding Site, Bloomberg reports
- $587.37 /
+17.23 (+3.02%) - 16:27 Today
- What You Missed On Wall Street On Wednesday
- 12:16 Today
- What You Missed On Wall Street This Morning
- 08:53 Today
- Fly Intel: Pre-market Movers
- 12/07/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $587.37 /
+17.23 (+3.02%) - 09:55 Today
- Early notable gainers among liquid option names on February 1st
- 01/10/23
- Early notable gainers among liquid option names on January 10th
|
|
Downgrade
| ShowHide Related Items >><< - 11:39 Today
- Qualtrics up 5% after Silver Lake says intends to submit bid
- 01/11/23
- Qualtrics to eliminate 270 roles, less than 5% of workforce
- 11/29/22
- AvePoint appoints Briggs to VP of U.S. Public Sector
- 01/27/23 BMO Capital
- SAP price target raised to $125 from $110 at BMO Capital
- 01/27/23 BMO Capital
- Qualtrics price target raised to $17 from $13 at BMO Capital
- 01/27/23 Barclays
- Qualtrics price target raised to $15 from $11 at Barclays
- 01/26/23 Oppenheimer
- Qualtrics price target raised to $17 from $14 at Oppenheimer
- 01/25/23
- Qualtrics sees FY23 adjusted EPS 20c-24c, consensus 10c
- 01/25/23
- Qualtrics sees adjusted Q1 EPS 1c-2c, consensus 1c
- 01/25/23
- Qualtrics reports Q4 EPS 3c, consensus 2c
- 10/24/22
- Qualtrics raises FY22 EPS view to 4c-5c from (9c)-(7c), consensus (7c)
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/26/23
- What You Missed On Wall Street This Morning
- 10/24/22
- Fly Intel: After-Hours Movers
- 09:40 Today
- Unusually active option classes on open February 1st
- 08:45 Today
- Largest borrow rate increases among liquid names
- 10/24/22
- Qualtrics International options imply 10.1% move in share price post-earnings
|
|
Downgrade
| ShowHide Related Items >><< - $16.37 /
+3.455 (+26.75%) - 08:47 Today
- Peloton not forecasting spike in churn rate
- 08:47 Today
- Peloton still sees revenue for the year to resemble seasonality of FY22
- 08:38 Today
- Peloton: Precor meets significant need in commercial marketplace
- 07:12 Today
- Peloton CEO says generated more revenue from subscriptions vs. hardware sales
- $16.37 /
+3.455 (+26.75%) - 01/30/23 Citi
- Peloton promotions drove improved traffic trends, says Citi
- 01/24/23 MKM Partners
- MKM Partners positive on Peloton heading into earnings
- 01/24/23 Baird
- Peloton downgraded to Neutral from Outperform at Baird
- 11/21/22 Cowen
- Peloton downgraded to Market Perform from Outperform at Cowen
- $16.37 /
+3.455 (+26.75%) - 07:24 Today
- Peloton sees Q3 revenue $690M-$715M, consensus $692.14M
- 07:21 Today
- Peloton reports Q2 EPS (98c), consensus (64c)
- 01/31/23
- Notable companies reporting before tomorrow's open
- 01/31/23
- Notable companies reporting before tomorrow's open
- $16.37 /
+3.455 (+26.75%) - 10/28/22
- Peloton co-founder doubled his pledge shares to cover margin calls, WSJ reports
- 10/27/22
- Peloton drops Kanye West music from platform, NY Post reports
- 10/11/22
- Peloton's Foley faced 'repeated' margin calls on money he borrowed, WSJ reports
- 10/06/22
- Peloton to cut 500 more jobs in turnaround effort, WSJ reports
- $16.37 /
+3.455 (+26.75%) - 16:27 Today
- What You Missed On Wall Street On Wednesday
- 12:16 Today
- What You Missed On Wall Street This Morning
- 08:53 Today
- Fly Intel: Pre-market Movers
- 01/24/23
- What You Missed On Wall Street On Tuesday
- $16.37 /
+3.455 (+26.75%) - 09:40 Today
- Unusually active option classes on open February 1st
- 01/30/23
- Peloton Interactive call volume above normal and directionally bullish
- 01/24/23
- Peloton Interactive put volume heavy and directionally bearish
- 01/06/23
- Peloton Interactive call volume above normal and directionally bullish
|
|
Hot Stocks
| ShowHide Related Items >><< - 12/14/22
- Northern Trust raises prime rate to 7.5% from 7%, effective December 15
- 11/02/22
- Northern Trust raises prime rate to 7% from 6.25%, effective November 3
- 09/21/22
- Northern Trust raises prime rate to 6.25%
- 09/21/22
- Northern Trust names Buzza global head, network managment, market strategy
- 01/20/23 Deutsche Bank
- Northern Trust price target lowered to $90 from $95 at Deutsche Bank
- 01/11/23 Deutsche Bank
- Northern Trust price target raised to $95 from $92 at Deutsche Bank
- 01/11/23 Deutsche Bank
- Deutsche ups BNY Mellon targets, initiates 'Buy Catalyst Call'
- 01/04/23 Goldman Sachs
- Northern Trust downgraded to Neutral from Buy at Goldman Sachs
- 01/19/23
- Northern Trust reports Q4 EPS 71c, consensus $1.80
- 10/19/22
- Northern Trust reports Q3 EPS $1.80, consensus $1.84
|
|
Upgrade
| |
|
Hot Stocks
| ShowHide Related Items >><< - 09:15 Today
- OSI Systems receives $3M order
- 01/17/23
- OSI Systems receives $200M+ international order for inspection system
- 09/19/22
- OSI Systems increases share repurchase program to 2M shares
- 08/30/22
- OSI Systems receives $22M security division order
- 01/26/23
- OSI Systems backs FY23 EPS view $6.02-$6.25, consensus $6.11
- 01/26/23
- OSI Systems reports Q2 adjusted EPS $1.19, consensus $1.17
- 10/27/22
- OSI Systems reports Q1 EPS 87c, consensus 80c
- 08/18/22
- OSI Systems sees FT23 EPS $6.02-$6.25, consensus $6.30
- 08/18/22
- Fly Intel: After-Hours Movers
|
